Meet The profesors
HomeEditionsAbout MTPAbout usContact
Breast CancerColorectal CancerGISTLung CancerNHL CancerProstate CancerRenal Cell Cancer
Meet The Professors: Volume 7, Issue 1
A case-based discussion on the management
of breast cancer in the adjuvant and metastatic settings
 
     
Moderator:    
Neil Love, MD    

Faculty:
   
Clifford Hudis, MD Sandra M Swain, MD  
Kathy D Miller, MD Eric P Winer, MD  
Edith A Perez, MD      


CME INFORMATION

FACULTY AFFILIATIONS AND DISCLOSURES

Case Studies

Case 2: A 56-year-old postmenopausal woman with poorly controlled diabetes, hypertension and cardiomyopathy with a 49 percent LVEF presents with a 5.3-cm, ER- and PR-positive, HER2-positive IDC (from the practice of Martha A Tracy, MD)

Case 3: A 62-year-old woman underwent a mastectomy for a 5-cm, ER-positive, PR-negative, HER2-positive IDC with 2/13 positive lymph nodes (from the practice of Scott A Tetreault, MD)

Case 4: A 42-year-old woman postoophorectomy presented with a well-differentiated, 9-mm, ER-positive, PR-negative, HER2-negative BC with cytokeratin-positive cells in one sentinel node (from the practice of Brenda Towell, MD)

Case 7: A 58-year-old woman presents with symptomatic pleural effusion and ER-positive, PR-borderline, HER2-negative cells consistent with BC 11 years after initial treatment for an IDC with 14/15 positive nodes (from the practice of Patricia A De Fusco, MD)

Case 8: A 50-year-old perimenopausal woman underwent bilateral mastectomies for a well-differentiated, 1.4- x 0.7-cm, strongly ER- and PR-positive, HER2-negative IDC with a small (>2-mm) focus of metastatic cells in one sentinel node (from the practice of Dean G Tsarwhas, MD)

ADDITIONAL CASES ON THE AUDIO PROGRAM

Case 1: A 59-year-old postmenopausal woman treated three years ago for a 2-cm, ER- and PR-positive, HER2-negative, node-positive infiltrating ductal carcinoma (IDC) presents with widespread, biopsy-confirmed bone and lung metastases (from the practice of Kenneth K Ng, MD)

Case 5: An 81-year-old woman noncompliant with adjuvant letrozole presents with a locally recurrent, Grade III, 5-mm, ER- and PR-positive, HER2-negative BC 18 months after initial treatment (from the practice of Margaret A Deutsch, MD)

Case 6: A 71-year-old woman has a 5.2-cm residual invasive lobular carcinoma with involvement of the nipple and 19/22 positive nodes after neoadjuvant TC and mastectomy for three ER- and PR-positive, HER2-negative BCs (from the practice of Alan B Astrow, MD)